Sven Ante Lundberg - 25 Mar 2024 Form 3 Insider Report for Homology Medicines, Inc. (QTTB)

Role
Director
Signature
/s/ Eric Bell, Attorney-in-Fact
Issuer symbol
QTTB
Transactions as of
25 Mar 2024
Net transactions value
$0
Form type
3
Filing time
27 Mar 2024, 17:14:21 UTC
Previous filing
02 Jun 2023
Next filing
09 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QTTB Common Stock 1,200 25 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QTTB Stock Option (Right to Buy) 25 Mar 2024 Common Stock 2,013 $3.13 Direct F1
holding QTTB Stock Option (Right to Buy) 25 Mar 2024 Common Stock 6,238 $3.13 Direct F2
holding QTTB Stock Option (Right to Buy) 25 Mar 2024 Common Stock 2,880 $7.29 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vested and became exercisable on July 26, 2019, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F2 25% of the shares underlying this option vested and became exercisable on September 17, 2020, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
F3 The shares underlying this option vest in sixteen (16) equal quarterly installments following December 2, 2020, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

Exhibit 24 - Power of Attorney